http://orcid.org/0000-0003-0988-6699
Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiaoyu Zhang, Weinan Li, Jialin Sun, Zhixin Yang, Qingxia Guan, Rui Wang, Xiuyan Li, Yongji Li, Yufei Feng & Yanhong Wang. (2020) How to use macrophages to realise the treatment of tumour. Journal of Drug Targeting 28:10, pages 1034-1045.
Read now
Read now
Articles from other publishers (31)
Andreas Pannek, Janine Becker-Gotot, Steven K. Dower, Anne M. Verhagen & Paul A. Gleeson. (2023) The endosomal system of primary human vascular endothelial cells and albumin–FcRn trafficking. Journal of Cell Science 136:15.
Crossref
Crossref
Michal Pyzik, Lisa K. Kozicky, Amit K. Gandhi & Richard S. Blumberg. (2023) The therapeutic age of the neonatal Fc receptor. Nature Reviews Immunology 23:7, pages 415-432.
Crossref
Crossref
Jill Barber, Zubida M. Al-Majdoub, Narciso Couto, Martyn Howard, Yasmine Elmorsi, Daniel Scotcher, Naved Alizai, Saskia de Wildt, Felix Stader, Armin Sepp, Amin Rostami-Hodjegan & Brahim Achour. (2023) Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling. European Journal of Pharmaceutical Sciences 182, pages 106375.
Crossref
Crossref
S. S. Justus Hosseini, Anna Dudakova, Karsten Kummer & Jana Zschüntzsch. (2022) SARS-CoV-2-Antikörper-Antwort auf die zweite COVID-19-Impfung bei neuromuskulären Patienten unter immunmodulierender TherapieSARS-CoV-2 antibody response to the second COVID-19 vaccination in neuromuscular disease patients under immune modulating treatment. Der Nervenarzt 93:12, pages 1219-1227.
Crossref
Crossref
Luladey Ayalew, Phyllis Chan, Zhilan Hu, Amy Shen, Eileen Duenas, Whitney Kirschbrown, Arthur J. SchickIIIIII, Yan Chen & Michael T. Kim. (2022) C-Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous Administration. Molecular Pharmaceutics 19:11, pages 4043-4054.
Crossref
Crossref
Juliette Lamamy, Anthony Larue, Julie Mariot, Christine Dhommée, Marie-Véronique Demattei, Yves Delneste & Valérie Gouilleux-Gruart. (2022) The neonatal Fc receptor expression during macrophage differentiation is related to autophagy. Frontiers in Immunology 13.
Crossref
Crossref
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, Arthur E. H. Bentlage, Ninotska I. L. Derksen, Julie Andries, Bianca Balbino, Magdalena Sips, Peter Ulrichts, Peter Verheesen, Hans de Haard, Theo Rispens, Savvas N. Savvides & Gestur Vidarsson. (2022) The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature Communications 13:1.
Crossref
Crossref
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Lene Støkken Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe & Jan Terje Andersen. (2022) Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications Biology 5:1.
Crossref
Crossref
Zhong Zhao, Zhi-Hong Shi, Chen-Jun Ye & Yun Zhang. (2022) A pore-forming protein drives macropinocytosis to facilitate toad water maintaining. Communications Biology 5:1.
Crossref
Crossref
E. Sally Ward, Deborah Gelinas, Erwin Dreesen, Jolien Van Santbergen, Jan Terje Andersen, Nicholas J. Silvestri, Joseph E. Kiss, Darrell Sleep, Daniel J. Rader, John J. P. Kastelein, Els Louagie, Gestur Vidarsson & Isabel Spriet. (2022) Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders. Frontiers in Immunology 13.
Crossref
Crossref
Shufang Liu & Dhaval K. Shah. (2022) Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics. Drug Metabolism and Disposition 50:6, pages 867-878.
Crossref
Crossref
Huiyu Hu, Jeremy Quintana, Ralph Weissleder, Sareh Parangi & Miles Miller. (2022) Deciphering albumin-directed drug delivery by imaging. Advanced Drug Delivery Reviews 185, pages 114237.
Crossref
Crossref
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, Matthieu Gracia, Aubin Pitiot, Caroline Denevault-Sabourin, Nicolas Joubert, Jean-Pierre Pouget, Valérie Gouilleux-Gruart, Nathalie Heuzé-Vourc’h, Débora Lanznaster, Sophie Poty & Thomas Sécher. (2022) Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics 233, pages 108022.
Crossref
Crossref
Paul R. V. Malik, Abdullah Hamadeh & Andrea N. Edginton. (2022) Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies. Pharmaceutical Research 39:2, pages 239-250.
Crossref
Crossref
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M. Nick, Elaine Stur, Pahul Hanjra, Dahai Jiang, Nicholas B. Jennings, Xiuhui Chen, Sara Corvigno, Deanna Glassman, Gabriel Lopez-Berestein, Jinsong Liu, Mien-Chie Hung & Anil K. Sood. (2022) Endothelial p130cas confers resistance to anti-angiogenesis therapy. Cell Reports 38:4, pages 110301.
Crossref
Crossref
Bruna Ferreira Leal & Carlos Alexandre Sanchez Ferreira. (2021) Ticks and antibodies: May parasite density and tick evasion influence the outcomes following immunization protocols?. Veterinary Parasitology 300, pages 109610.
Crossref
Crossref
Souwelimatou Amadou Amani, Gillian A. Lang, Jimmy D. Ballard & Mark L. Lang. (2021) The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility. Infection and Immunity 89:10.
Crossref
Crossref
Imke Rudnik-Jansen & Kenneth A. Howard. (2021) FcRn expression in cancer: Mechanistic basis and therapeutic opportunities. Journal of Controlled Release 337, pages 248-257.
Crossref
Crossref
Cláudia Azevedo, Soraia Pinto, Sopisa Benjakul, Jeannette Nilsen, Hélder A. Santos, Giovanni Traverso, Jan Terje Andersen & Bruno Sarmento. (2021) Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery. Advanced Drug Delivery Reviews 175, pages 113778.
Crossref
Crossref
Silvia Lombardi, Kristin H. Aaen, Jeannette Nilsen, Mattia Ferrarese, Torleif T. Gjølberg, Francesco Bernardi, Mirko Pinotti, Jan T. Andersen & Alessio Branchini. (2021) Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity. British Journal of Haematology 194:2, pages 453-462.
Crossref
Crossref
Gilles Thibault, Gilles Paintaud, Hsueh Sung, Laurie Lajoie, Edouard Louis, Celine Desvignes, Hervé Watier, Valérie Gouilleux-Gruart & David Ternant. (2021) Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients. International Journal of Molecular Sciences 22:11, pages 6051.
Crossref
Crossref
Timothy Qi & Yanguang Cao. (2021) In Translation: FcRn across the Therapeutic Spectrum. International Journal of Molecular Sciences 22:6, pages 3048.
Crossref
Crossref
Wei Sun, Priyanka Khare, Xiaoli Wang, Dilip K. Challa, Benjamin M. Greenberg, Raimund J. Ober & E. Sally Ward. (2021) Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease. Molecular Therapy 29:3, pages 1312-1323.
Crossref
Crossref
Kristin Hovden Aaen, Aina Karen Anthi, Inger Sandlie, Jeannette Nilsen, Simone Mester & Jan Terje Andersen. (2021) The neonatal Fc receptor in mucosal immune regulation. Scandinavian Journal of Immunology 93:2.
Crossref
Crossref
Sofia Rossini, Rémi Noé, Victoria Daventure, Maxime Lecerf, Sune Justesen & Jordan D. Dimitrov. (2020) V Region of IgG Controls the Molecular Properties of the Binding Site for Neonatal Fc Receptor. The Journal of Immunology 205:10, pages 2850-2860.
Crossref
Crossref
Diana Cadena Castaneda, Guillaume Brachet, Caroline Goupille, Lobna Ouldamer & Valérie Gouilleux‐Gruart. (2020) The neonatal Fc receptor in cancer FcRn in cancer. Cancer Medicine 9:13, pages 4736-4742.
Crossref
Crossref
Angelina Mimoun, Sandrine Delignat, Ivan Peyron, Victoria Daventure, Maxime Lecerf, Jordan D. Dimitrov, Srinivas V. Kaveri, Jagadeesh Bayry & Sébastien Lacroix-Desmazes. (2020) Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance. Frontiers in Immunology 11.
Crossref
Crossref
Paul R. V. Malik & Andrea N. Edginton. (2019) Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants. The Journal of Clinical Pharmacology 60:4, pages 466-476.
Crossref
Crossref
L. J. Blumberg, J. E. HumphriesS. D. JonesL. B. PearceR. HolgateA. Hearn, J. CheungA. Mahmood, B. Del Tito, J. S. GraydonL. E. StolzA. Bitonti, S. PurohitD. de Graaf, K. Kacena, J. T. AndersenG. J. ChristiansonD. C. RoopenianJ. J. HubbardA. K. GandhiK. Lasseter, M. Pyzik & R. S. Blumberg. (2019) Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses. Science Advances 5:12.
Crossref
Crossref
Simone Schadt, Simon Hauri, Filipe Lopes, Martin R. Edelmann, Roland F. Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B. Roth, Franz Schuler, Wolfgang F. Richter & Christoph Funk. (2019) Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug Metabolism and Disposition 47:12, pages 1443-1456.
Crossref
Crossref
Michal Pyzik, Kine M. K. Sand, Jonathan J. Hubbard, Jan Terje Andersen, Inger Sandlie & Richard S. Blumberg. (2019) The Neonatal Fc Receptor (FcRn): A Misnomer?. Frontiers in Immunology 10.
Crossref
Crossref